Twitter | Pretraživanje | |
Xconomy
With $45M, Expects Big Things From Tiny CRISPR Cas14 - by ; insight from CEO
Mammoth Biosciences set out to develop CRISPR-based diagnostics that could be faster and cheaper than what’s available today. Those diagnostics are still
Xconomy Xconomy @Xconomy
Reply Retweet Označi sa "sviđa mi se" More